InvestorIdeas breaking stock market news: Investor Ideas New Stocks to Watch in Life Sciences and AI; (TSXV: $ZCT.V) (TSXV: $IOT.V) (Nasdaq: $SPRC) (OTCQB: $BIXT) (NASDAQ: $KITT) (TSX-V: $XBOT.V; OTC: $XBOTF) (OTCQB: $WYTC) (OTCQB: $RELT)

Investor Ideas New Stocks to Watch in Life Sciences and AI; (TSXV: $ZCT.V) (TSXV: $IOT.V) (Nasdaq: $SPRC) (OTCQB: $BIXT) (NASDAQ: $KITT) (TSX-V: $XBOT.V; OTC: $XBOTF) (OTCQB: $WYTC) (OTCQB: $RELT)

February 14, 2025 – (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces today’s roundup of stocks to watch in the Life Sciences and AI sectors.

The newest life sciences companies are involved in woman’s health, microbiology testing, cannabinoid pharmaceuticals and drug development using AI.

The latest AI companies are involved in autonomous robotics, AI/sensor technology and marketing and business solutions.

New stocks added today: Zero Candida Technologies Inc. (TSXV:ZCT), Innovotech, Inc. (TSXV: IOT), SciSparc Ltd. (Nasdaq: SPRC), Bioxytran, Inc. (OTCQB: BIXT) Nauticus Robotics, Inc. (NASDAQ:KITT), Realbotix Corp. (TSX-V: XBOT; OTC: XBOTF), Wytec International, Inc. (OTCQB: WYTC), Onar, Inc. (OTCQB: RELT).

Read this in full at https://www.investorideas.com/news/2025/main/02141Stocks.asp

Investor Ideas is always researching and searching for new stocks to add to our growing list of free stock directories. The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

New Stocks Added to the Life Sciences/Biotech Directories:

Zero Candida Technologies Inc. (TSXV:ZCT) is a publicly traded FemTech company pioneering innovative solutions in women's health. The company is developing an AI-driven, tampon-like device that uses a therapeutic light source with a selected wave-length and intensity to effectively treat the Candida fungus with a demonstrated 99.999% success rate in POC. Vulvo-Vaginal Candidiasis ("VVC") affects about 75% of women globally, with 138witheach year 138 million women are affected world-wide and 492 million over their lifetime. Recurrent VVC (4 or more episodes per year) is increasingly documented to become drug resistant to existing treatments, since the root cause is poorly understood and addressed. ZCT has successfully completed a safety trial using its pre-clinical device in large animals (sheep), and is finalizing their device for human use in preparation for an upcoming clinical trial, that they secured both funding and agreements with leading hospitals in Israel and Europe for. The Company continues to grow it's global patent portfolio with applications filed in the United States, Brazil and Europe, and was recently granted a final patent in South Africa. With hybrid medicine and technology-based diagnostics, ZCT is addressing unmet needs in women's healthcare and expanding access to underserved populations, bringing the field of gynecology into the 21st century.

Innovotech, Inc. (TSXV: IOT) is a Canadian biotechnology company owning proprietary intellectual property, conducting contract research, and owning and providing proprietary devices for testing in multiple applications in microbiology

SciSparc Ltd. (Nasdaq: SPRC) is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists. SciSparc’s focus is on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. With this focus, the Company is currently engaged in the following drug development programs based on THC and/or non-psychoactive cannabidiol: SCI-110 for the treatment of Tourette Syndrome, for the treatment of Alzheimer's disease and agitation; and SCI-210 for the treatment of autism and status epilepticus. The Company also owns a controlling interest in a subsidiary whose business focuses on the sale of hemp seeds’ oil-based products on the Amazon.com Marketplace.

Bioxytran, Inc. (OTCQB: BIXT) is a clinical stage biotechnology company pioneering a library of novel complex carbohydrate structures using artificial intelligence software that interprets the Nuclear Magnetic Resonance imaging of druggable targets like the galectin fold to create a rational drug design. The leading drug candidates vetted by in vitro testing, are capable of neutralizing viruses. The peer-reviewed discovery of the galectin fold located on the spike proteins of viruses such as COVID-19, RSV, and H1N1 demonstrate there exists a conserved region on the spike in which Bioxytran’s molecules achieve virus neutralization. The extent of the carbohydrate structure’s ability to neutralize untested viruses is unknown just like the initial discovery of antibiotics last century and its ability to treat a broad spectrum of bacterial infections. Applications of this platform technology extend to the treatment of significant unmet medical needs in virology, degenerative disease, and hypoxia. The leading drug candidate, Prolectin-M, is a new class of antiviral drug designed to antagonize galectins implicated in inflammatory, fibrotic, and malignant diseases. Bioxytran’s other development programs are for pulmonary fibrosis and stroke treatment.

New Stocks Added to the AI/Tech Directories:

Nauticus Robotics, Inc. (NASDAQ:KITT) develops autonomous robots for the ocean industries. Autonomy requires the extensive use of sensors, artificial intelligence, and effective algorithms for perception and decision allowing the robot to adapt to changing environments. The company's business model includes using robotic systems for service, selling vehicles and components, and licensing of related software to both the commercial and defense business sectors. Nauticus has designed and is currently testing and certifying a new generation of vehicles to reduce operational cost and gather data to maintain and operate a wide variety of subsea infrastructure. Besides a standalone service offering and forward-facing products, Nauticus' approach to ocean robotics has also resulted in the development of a range of technology products for retrofit/upgrading traditional ROV operations and other third-party vehicle platforms. Nauticus' services provide customers with the necessary data collection, analytics, and subsea manipulation capabilities to support and maintain assets while reducing their operational footprint, operating cost, and greenhouse gas emissions, to improve offshore health, safety, and environmental exposure.

Realbotix Corp. (TSX-V: XBOT; OTC: XBOTF; FSE: 76M0.F) Transcending the barrier between man and machine, Realbotix creates customizable, full-bodied, humanoids with AI integration that improve the human experience through connection, learning and play. Manufactured in the USA, Realbotix has a reputation for having the highest quality humanoid robots and the most realistic silicone skin technology. Realbotix sells humanoid products with embedded AI to enable human-like social interactions and intimate connections with humans. Our integration of hardware and AI software results in the most human looking full-sized robots on this planet. We achieve this through patented technologies that deliver human-like appearance and movements. This versatility makes our robots and their personalities customizable and programmable to suit a wide variety of use cases.

Wytec International, Inc. (OTCQB: WYTC) is a 5G network development company with proprietary, patent, and patent-pending AI/sensor technology designed to support gunshot detection, drug sensing technology for public safety, and distance learning solutions for schools and cities.

Onar, Inc. (OTCQB: RELT) is a dynamic marketing and business solutions network, currently publicly traded as Reliant Holdings, Inc. with plans to become Onar Holding Corporation in the near future. ONAR's mission is to provide unparalleled service through an integrated, AI-driven approach, leveraging its diverse brand family's strengths. Committed to honor, candor, and best-in-class results, ONAR aims to lead the industry by example, ensuring every client relationship is deeply rooted in trust and excellence.

About Investorideas.com - Big Investing Ideas

Investorideas.com is the go-to platform for big investing ideas. From breaking stock news to top-rated investing podcasts, we cover it all. Our original branded content includes podcasts such as Exploring Mining, Cleantech, Crypto Corner, Cannabis News, and the AI Eye. We also create free investor stock directories for various sectors, including gaming, biotech, tech and sports. Public companies within the sectors we cover can use our news publishing and content creation services to help tell their story to interested investors. Paid content is always disclosed.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Learn more about our news, PR and social media, podcast services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

Learn more about advertising and guest posts

https://www.investorideas.com/Advertise/